Complications Associated With Partial Nephrectomy for Renal Cancer

Status Completed

Clinical Trial Summary

This paper evaluates the initial complications and the complications two years postoperatively necessitating re-hospitalisation for three surgical procedures for renal tumour partial nephrectomy .

Clinical Trial Description

This paper evaluates the initial complications and the complications two years postoperatively necessitating re-hospitalisation for three surgical procedures for renal tumour partial nephrectomy (open (OPN), standard laparoscopy (LPN) and robot assisted laparoscopy (RAPN)) in 2016-2017 in France (9119 initial hospitalisations included 4035 OPN, 1900 RAPN, 1709 LPN). The investigators have extracted for these all hospitalisations from the French national hospital data base (PMSI-MCO). The investigators concluded mini-invasive and robotic surgery had lower morbidity and a shorter initial hospitalisation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05168761
Study type	Observational
Source	Central Hospital, Nancy, France
Contact
Status	Completed
Phase
Start date	January 1, 2016
Completion date	December 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03634540` - A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)	Phase 2
Recruiting	`NCT03175224` - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors	Phase 2
Active, not recruiting	`NCT00531284` - Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma	Phase 1/Phase 2
Recruiting	`NCT05842044` - NSAID Use After Robotic Partial Nephrectomy	Phase 2
Recruiting	`NCT05387863` - Decision Aid (DA) for Renal Patients	N/A
Terminated	`NCT02669914` - MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors	Phase 2
Withdrawn	`NCT03390413` - Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer	N/A
Completed	`NCT04933604` - LPN in Patients With High-complex Renal Tumors
Recruiting	`NCT05119335` - A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma	Phase 1/Phase 2
Active, not recruiting	`NCT03203473` - Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)	Phase 2
Suspended	`NCT04115254` - Stereotactic Magnetic Resonance Guided Radiation Therapy	N/A
Enrolling by invitation	`NCT02609269` - Decipher Genomics Resource for Intelligent Discovery
Terminated	`NCT01453595` - BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)	Phase 1/Phase 2
Completed	`NCT01444456` - Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia	N/A
Completed	`NCT02811250` - Stereotactic Radiotherapy for Renal Cancers	N/A
Completed	`NCT00399152` - Perifosine + Sunitinib Malate for Patients With Advanced Cancers	Phase 1
Completed	`NCT00398814` - Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers	Phase 1
Completed	`NCT00458536` - Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF	Phase 1/Phase 2
Recruiting	`NCT03693014` - A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors	Phase 2
Completed	`NCT00418496` - Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma	Phase 1